EQUITY STRATEGIES

Sennosen invests in the equity securities of companies listed in the United States. We seek to generate alpha by combining fundamental stock selection with proprietary portfolio construction methodologies grounded in factor-based risk management.

Quantitative Strategies

Sennosen’s quantitative strategies generate alpha by combining fundamental research with statistical models to execute on investment opportunities resulting from heuristic-based top-down capital markets analysis.

TECHNOLOGY DEVELOPMENT

We rely on proprietary technology to run our investment activities. In 2017, we contributed our technology to an independent company, c+o holdings, to make our capabilities available to other sectors including nutrition science and pharmaceutical drug development.

Sennosen LLC was founded in 2014

LOCATED IN SAN FRANCISCO

Since inception, we have deployed a hybrid approach that combines discretionary and systematic strategies. We rely on discretionary analysis to identify investments in public equity securities across most sectors. Our goal is to provide best-in-class performance guided by core values of honesty and continuous learning.